Sunday, October 12, 2025
  • Login
CEO North America
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
CEO North America
No Result
View All Result

CEO North America > News > FDA approves J&J’s single-shot Covid vaccine

FDA approves J&J’s single-shot Covid vaccine

in News
- FDA approves J&J’s single-shot Covid vaccine
Share on LinkedinShare on WhatsApp

Unlike Pfizer’s and Moderna’s vaccines, J&J’s one-dose regimen eliminates the need for patients to return for a second dose and can be stored at refrigerator temperatures for months.

The Food and Drug Administration has approved Johnson & Johnson’s Covid-19 vaccine for emergency use, giving the United States important backup in the fight against the pandemic.

The FDA’s emergency use authorization should significantly aid the federal government’s plan to distribute nearly 4 million doses of J&J’s vaccine to states, pharmacies and community health centers across the nation next week.

J&J’s vaccine “makes it operationally easier in lots of contexts,” Dr. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases, told the Journal of the American Medical Association during a Q&A event on Friday. “I expect lots of considerations state health departments are having around these vaccines is more about the ease of use of the J&J vaccine and how it might be better suited for some populations.”

The company expects to deliver 20 million doses by the end of March, J&J’s vice president of U.S. medical affairs, Dr. Richard Nettles, told House lawmakers on Tuesday. J&J has a deal with the U.S. government to supply 100 million doses of its vaccine by the end of June, and U.S. officials say they are working with the company to ramp up supply as quickly as possible.

Tags: #J&JCOVID-19Vaccine

Related Posts

Levi Strauss taps Michelle Gass as new CEO
News

Levi Strauss raises full-year profit forecast

Bessent narrows down Fed chair contenders to five
News

Bessent narrows down Fed chair contenders to five

Qualcomm to ax 1200 California staffers
News

Qualcomm stock drops as China opens antitrust probe

Taiwanese chipmaking giant TSMC to invest $100 billion in U.S.
News

TSMC revenue jumps 30% in Q3

Ferrari unveils 2030 strategic plan
News

Ferrari unveils 2030 strategic plan

Disney hires PepsiCo CFO as new finance chief
News

PepsiCo announces Steve Schmitt as CFO

Constellation Brands cites challenging socioeconomic environment for lowered outlook
News

Constellation Brands cites challenging socioeconomic environment for lowered outlook

Countries repatriate gold after Russian sanctions
News

Gold and Bitcoin surge as “safe” investments reach record demand

Domino’s announces crave-worthy brand reboot
News

Domino’s announces crave-worthy brand reboot

Beijing calls tariffs “blackmail”
News

China tipped to grow by 4.8% despite tariff pressures

No Result
View All Result

Recent Posts

  • Ha Long Bay’s mystical beauty
  • Taylor Swift Conquers Her Biggest Stage Yet on ‘The Life of a Showgirl’
  • Levi Strauss raises full-year profit forecast
  • Bessent narrows down Fed chair contenders to five
  • The silent killer increases your risk of stroke and dementia. Here’s how to control it

Archives

Categories

  • Art & Culture
  • Business
  • CEO Interviews
  • CEO Life
  • Editor´s Choice
  • Entrepreneur
  • Environment
  • Food
  • Health
  • Highlights
  • Industry
  • Innovation
  • Issues
  • Management & Leadership
  • News
  • Opinion
  • PrimeZone
  • Printed Version
  • Technology
  • Travel
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

  • News
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

CEO North America © 2024 - Sitemap

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.